Symposium

 

final program

 

 

The symposium at a glance

TIME TUESDAY   FEB 27 TIME WEDNESDAY FEB 28 TIME THURSDAY MARCH 1
08.30‐09.00  Opening Ceremony        
09.00-10.30

1. Pathology & Pathobiology
Marc Humbert, Marlene Rabinovitch

09.00-10.30

6. Risk Stratification and Medical Therapy of Pulmonary Arterial Hypertension
Nazzareno Galiè, Vallerie V. McLaughlin

09.00-10.30

10. PH due to Chronic Lung Diseases
Werner Seeger, Steven Dale Nathan

10.30-11.00 coffee break 10.30-11.00 coffee break 10.30-11.00 coffee break
11.00-12.30 2. Genetics & Genomics
Nicholas Morrell, James E. Loyd
11.00-12.30 7. Right Ventricular Assistance and Lung Transplantation
Walter Klepetko, Marius Hoeper
11.00-12.30

11. CTEPH
Ardeschir H. Ghofrani, Nick H. Kim

12.30-13.00  Best Poster Awards Ceremony 12.30-14.00 Lunch and posters 12.30-14.00 Lunch and posters
13.00-14.00 Lunch and posters 14.00-15.30 8. Trials Design & New Therapies for Pulmonary Arterial Hypertension
Lewis J. Rubin, Olivier Sitbon
14.00-15.30

12. Pediatric PH
Erika Berman Rosenzweig, Rolf M.F. Berger

14.00-15.30 3. Pathophysiology of the RV and of the Pulmonary Circulation
Robert Naeije, Anton Vonk Noordegraaf

15.30-16.00 coffee break 15.30-16.00 coffee break
15.30-16.00 coffee break 16.00-17.30 9. PH due to Left Heart Diseases
Jean Luc Vachiery, Teresa De Marco
16.00-17.30

13. Patients' Perspectives
Michael D. McGoon, Pisana Ferrari

16.00-17.30 4. PH Haemodynamic Definitions and Clinical Classifications and Characteristics of Specific PAH Subgroups
Gerald Simonneau, Rogerio Souza
       
17.30-19.00 5. Diagnosis of Pulmonary Hypertension
Adaani Frost, Adam Torbicki
       

 

 

The Symposium Steering Committee

Adaani Frost, MD
Houston, TX – USA

Nazzareno Galiè, MD
Bologna, Italy

Ardeschir Ghofrani, MD
Giessen, Germany              

Marc Humbert, MD
Paris, France

Anne Margaret Keogh, MD             
Sydney, Australia

Michael McGoon, MD
Rochester, MN – USA

Vallerie V. McLaughlin, MD
Ann Arbor, MI - USA

Nicholas Morrell, MD
Cambridge, UK

Lewis J. Rubin, MD
San Diego, CA – USA

Werner Seeger, MD
Giessen, Germany

Gérald Simonneau, MD
Paris, France

Rogerio Souza, MD
Sao Paulo, Brazil

The Symposium Thirteen Task Forces:

  1. Pathology & Pathobiology
  2. Genetics & Genomics
  3. Pathophysiology of the Rv and of the Pulmonary Circulation
  4. PH Haemodynamic Definitions and Clinical Classifications and Characteristics of Specific PAH Subgroups
  5. Diagnosis of Pulmonary Hypertension 
  6. Risk Stratification and Medical Therapy of Pulmonary Arterial Hypertension
  7. Right Ventricular Assistance and Lung Transplantation
  8. Trials Design & New Therapies for Pulmonary Arterial Hypertension
  9. PH due to Left Heart Diseases
  10. PH due to Chronic Lung Diseases
  11. CTEPH
  12. Pediatric PH
  13. Patients Perspectives

 

The Symposium Secretariat

logoiec

I&C s.r.l.
Via Andrea Costa, 202/6
40134 Bologna (IT)

Stefania Parolari and Giulia Delia

Ph: +39 - (0)51.614.4004
Fax: +39 - (0)51.614.2772

@
For registrations and hotel booking: registrations@wsph2018.com

For abstract submission: abstracts@wsph2018.com

For sponsorship: info@wsph2018.com